PDLI

PDL BioPharma, Inc.
PDLI

Overview Fund Activity
Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

152 hedge funds and large institutions have $329M invested in PDL BioPharma, Inc. in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 56 reducing their positions, and 25 closing their positions.

Holders
152
Holders Change
-11
Holders Change %
-6.75%
% of All Funds
3.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
39
Reduced
56
Closed
25
Calls
$334K
Puts
$58K
Net Calls
+$276K
Net Calls Change
+$359K

Top Buyers

1
KCM
1
Kennedy Capital Management
Missouri
$18.6M
2
BIP
2
Brandes Investment Partners
California
$10.4M
3
AC
3
Armistice Capital
New York
$4.73M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$2.34M
5
Citadel Advisors
5
Citadel Advisors
Florida
$11.6M

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$27.5M
2
BlackRock
2
BlackRock
New York
$32.9M
3
AQR Capital Management
3
AQR Capital Management
Connecticut
$7.61M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$558K
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$7.36M
Name Market Value Shares Shares
Change 		Shares
Change %
WT
176
Whittier Trust
California
$0 20 – –
CFGS
177
Concourse Financial Group Securities
Alabama
– – – –
Group One Trading
178
Group One Trading
Illinois
– – – –
SWM
179
Selective Wealth Management
Virginia
$0 140 +140 New
4 5 6 7
8